Drug Approval | April 23, 2026
Cipla’s generic Ventolin HFA secures USFDA approval
Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market
Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market
The system is powered by BrainSense technology, which has received approval from USFDA
C. P. Radhakrishnan urged graduates to uphold ethical standards and maintain a commitment to patient care
CLIRNET plans to expand globally and improve how medical knowledge is shared and used in practice
The collaboration underscores a broader industry shift toward hybrid research models that integrate computational biology with advanced experimental systems
Bulling brings extensive experience across the biopharma and CDMO landscape, with leadership roles spanning both drug substance and drug product operations
These findings help explain how relapse-triggering memories can persist alongside those that support recovery
Manoj has over two decades of experience in healthcare operations and biomedical engineering
C-CAMP–Imperial College London partnership to boost biotech research, startup exchange, and translational innovation through a five-year collaboration
IgAN is a rare, progressive kidney disease driven by abnormal IgA immune complexes that deposit in the kidneys
Subscribe To Our Newsletter & Stay Updated
